Form 4: Alector's Chief Medical Officer, Gary Romano, Reports Acquisition of Restricted Stock Units

A Form 4 filing reveals that Alector's Chief Medical Officer, Gary Romano, acquired 184,380 restricted stock units (RSUs) on October 1, 2024.

Summary

• Gary Romano, the Chief Medical Officer of Alector, Inc. (ALEC), filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on October 1, 2024.
• Romano acquired 184,380 shares of common stock in the form of restricted stock units (RSUs).
• These RSUs vest in 12 equal quarterly installments starting on December 1, 2024.
• Following the reported transaction, Romano beneficially owns 364,175 shares of Alector common stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard SEC filing related to executive compensation. The acquisition of RSUs can be seen as a positive sign of confidence, but it's not a major event.

Positives

• The acquisition of RSUs by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule of the RSUs suggests a long-term commitment from the Chief Medical Officer to the company's success.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing is specific to Alector and its executive.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a key executive.

Key Dates